One2One Partnering – PROMOTE AND ESTABLISH
BIOHK2021 is your 1st place to find global partners to drive your project to its next stage. One2One partnership intends to aid attendees in identifying and connecting prospective partners in the form of investors, analysts and partnering companies for future collaborations. With the BIOHK2021 One2One Partnering System, you have access to 300+ companies and can easily identify those interested in your research and open to licensing deals. Align your goals and maximize your returns with others investing in the future of biotech. In partnering meetings, you can:
- Establish relationship with pharmaceutical and biotech companies
- Promote the strengths of your departments and faculties
- Discuss current and future licensing opportunities
- Opportunities for investors to provide business advice to technology inventors
- Build promising partnerships across the fields
One2one Partnering process and steps:
BIOHK2021 exhibitors and conference attendees would be free to register the system now.
The matching system will open in the End of October 2021.
If you have any questions, our team will be more than happy to help you plan your experience.
Please contact us at info@bio-hk.com
BIOHK2021 Convention Participating Companies
| Adicon Clinical Laboratories | Affix Capital | AlphaSmart World Limited |
| AML Holdings Limited | Aptorum Group | ASC Therapeutics, Inc. |
| Asia Investment Fund Management Limited | Asian Fund for Cancer Research Limited | Ausvic Capital Limited |
| Cathay Capital | Center for Chinese Medicine R & D | Chime Biologics (Wuhan) Co.,Ltd. |
| City University of Hong Kong | CW Data Technologies | D&D Electronics Co., Ltd |
| Deloitte | eChinaHealth | European Federation of Biotechnology |
| Finet Group Ltd | Food and Environmental Hygiene, Food and Health Bureau, Government Secretariat HKSAR | Galaxy Treasure Group |
| Global Bio & Investment Monthly | Good Health Capital (New York) | Great Treasure International |
| Greater Bay Area Biotech Alliance | Guangdong Medical Valley (GDMV) | Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences |
| Hai Kang Life Corporation Limited | HKEX Group | Hong Kong Agriculture, Fisheries and Conservation |
| Hong Kong Association of the Pharmaceuticals Industry | Hong Kong Innovation and Technology Commission | Hong Kong Intellectual Property Department |
| Hong Kong Science and Technology Park | Hong Kong Tourism Board | Hong Kong Trade and Industry Department |
| Hong Kong University of Science and Technology | Incando Therapeutics | Institute of Chinese Medical Sciences, University of Macau |
| International Iberian Nanotechnology Laboratory | InvestHK | Johnson & Johnson (Hong Kong) Limited |
| Koln 3D Technology (Medical) Limited | Lee’s Pharmaceutical Holdings Limited | Liberi Group |
| LiLaw Inc. | Lo Ka Chung Charitable Foundation | Macau International Healthcare Think Tank |
| Marathon Venture Partners | McKinsey & Company | MGI |
| Ming-Wai Lau Centre for Reparative Medicine, HK node, Karolinska Institutet (KI), Sweden. | National Institute of Metrology, China | National Foundation for Cancer Research |
| Novotech CRO | Pacific Life Assurance Co., Ltd. | Pan Asia Venture Development Platform (PAVD) |
| Pangenia Inc and DiagCor Life Science Ltd. | Portfolio Management and Research | Powder Pharmaceuticals Incorporated |
| Queens (Shenzhen) Biotechnology Co., Ltd. | Ryoden Medical Holdings Limited | SenseTime Hong Kong |
| Serica Capital | Shanghai Epimab Biotherapeutics Co. , Ltd | Shenzhen Association for Science and Technology |
| Shenzhen Govita Medical Laboratory | Shenzhen International Institute for Biomedical Research | SPARQ Capital |
| The Bayhelix Group | The Chinese University of Hong Kong | Tiang & Partners |
| Tronex (Hong Kong) Limited | Torch High Technology Industry Development Center Ministry of Science and Technology | Winner Medical Group |
| Wise Ally Holdings Ltd | WuXi AppTec Co., Ltd. |